李智宇, 崔修铮, 邵永孚, 隋永双. 恶性腹膜间皮瘤的诊治体会[J]. 中国肿瘤临床, 2007, 34(23): 1365-1367.
引用本文: 李智宇, 崔修铮, 邵永孚, 隋永双. 恶性腹膜间皮瘤的诊治体会[J]. 中国肿瘤临床, 2007, 34(23): 1365-1367.
Li Zhi-yu, Cui Xiu-zheng, Shao Yong-fu, . Diagnosis and Management of Patients with Malignant Peritoneal Mesothelioma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(23): 1365-1367.
Citation: Li Zhi-yu, Cui Xiu-zheng, Shao Yong-fu, . Diagnosis and Management of Patients with Malignant Peritoneal Mesothelioma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 34(23): 1365-1367.

恶性腹膜间皮瘤的诊治体会

Diagnosis and Management of Patients with Malignant Peritoneal Mesothelioma

  • 摘要: 目的:提高对恶性腹膜间皮瘤的诊断和治疗水平。方法:对我院40年来收治的22例恶性腹膜间皮瘤患者的临床资料结合相关文献进行回顾性分析。结果:22例收治经病理证实的患者,男性9例,女性13例,年龄18~72岁,13例行减瘤手术+腹腔或/和全身化疗,1例行手术减瘤+腹部放疗;4例行剖腹探查+腹腔及全身化疗;1例未手术,仅行腹腔+全身化疗;3例未手术,仅行全身化疗。经治疗后随访中位生存期18.5月,3例存活超过5年。结论:恶性腹膜间皮瘤诊断困难,易误诊,预后差,主要依靠剖腹探查、腹水细胞学、B超引导穿刺活检、腹腔镜活检等方法,治疗主要以手术切除减瘤术结合全身化疗的综合治疗为主要手段。

     

    Abstract: Objective: To summarize the experience of diagnosis and management of malignant peritoneal mesothelioma. Methods: We reviewed the clinical data from 22 patients with malignant peritoneal mesothelioma who were admitted in our hospital in the past 40 years. Results: All of the diagnosis were proved pathologically, 9 males and 13 females, with a median age of 49,(range 18~72 years). Thirteen cases underwent cytoreductive surgery and intraperitoneal and/or systematic chemotherapy, 1 case received cytoreductive surgery and abdominal regional radiotherapy, 4 cases had laparotomy exploration and intraperitoneal and/or systematic chemotherapy, 1 case received intraperitoneal and systematic chemotherapy without surgery, and 3 cases only received systematic chemotherapy. The median survival time was 18.5 months, and there were 3 patients who survived over 5 years. Conclusion:The diagnosis of malignant peritoneal mesothelioma is difficult, and its prognosis is poor. Diagnostic methods include laparotomy exploration, ascites cytological examination, fine needle biopsy guided by B- US, and biopsy by laparoscope. Surgical cytoreduction combined with chemotherapy is the main management.

     

/

返回文章
返回